Overall rank by patents
#7,863
Across all tracked assignees
USPTO PatentsView assignee record - 41 granted patents across 48 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01J (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS).
The verdict
Imerys holds 41 US patents across 48 technology areas, rank #7,863 of 50,000 tracked assignees.
Imerys USA, Inc. has been granted 41 US utility patents between 2017 and 2025, placing Imerys USA, Inc. at rank #7,863 across all assignees tracked by PlainPatent. This portfolio spans 48 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in B01J (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS). As a US Corporation, Imerys USA, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Imerys sits between INHA University Research AND Business Foundation (41 patents, rank #7,859) and JDS Uniphase Corporation (41 patents, rank #7,867) - the closest US assignees by grant volume. The composite Innovation Score of 51.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 33 grants, compared with 8 in the 2015–2019 window, a +313% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Imerys USA, Inc.'s 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 48 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Imerys USA, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
41 patents
INSTITUTE OF PHYSICS, THE CHINESE ACADEMY OF SCIENCES
41 patents
INTACT VASCULAR, INC.
41 patents
IWIS MOTORSYSTEME GMBH & CO. KG
41 patents
Impossible Foods Inc.
41 patents
Inventec Appliances (Shanghai) Co., Ltd.
41 patents
JAPAN POLYETHYLENE CORPORATION
41 patents
JDS Uniphase Corporation
41 patents
Imerys USA, Inc.
41 patents
What this shows Imerys holds 41 patents at rank #7,863, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #7,863 in granted patent volume.
Other assignees with the most granted patents in Imerys's primary technology class.
Imerys's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 2.4% |
| 2018 | 4 | 9.8% |
| 2019 | 3 | 7.3% |
| 2020 | 9 | 22.0% |
| 2021 | 8 | 19.5% |
| 2022 | 5 | 12.2% |
| 2023 | 7 | 17.1% |
| 2024 | 1 | 2.4% |
| 2025 | 3 | 7.3% |
Top 15 of 48 technology areas
Overall rank by patents
#7,863
Across all tracked assignees
51.1 out of 100
How to use this portfolio
Imerys's 41 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.